Otom, Antonia F.

HRN: 26-64-06  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/07/2025
02/15/2025
IV
600mg
Qid
Bullous Impetigo
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: